{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/405257730",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1426309905"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/674464254",
    "http://id.who.int/icd/release/11/2024-01/mms/1394687071",
    "http://id.who.int/icd/release/11/2024-01/mms/102709764",
    "http://id.who.int/icd/release/11/2024-01/mms/1376183765",
    "http://id.who.int/icd/release/11/2024-01/mms/1936492387",
    "http://id.who.int/icd/release/11/2024-01/mms/405257730/other",
    "http://id.who.int/icd/release/11/2024-01/mms/405257730/unspecified"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#405257730",
  "code": "4A85.0",
  "source": "http://id.who.int/icd/entity/405257730",
  "classKind": "category",
  "foundationChildElsewhere": [
    {
      "label": {
        "@language": "en",
        "@value": "Drug eruptions"
      },
      "foundationReference": "http://id.who.int/icd/entity/923546127",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/923546127"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Drug-induced bronchospasm"
      },
      "foundationReference": "http://id.who.int/icd/entity/667435406",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/667435406"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Drug-induced aplastic anaemia"
      },
      "foundationReference": "http://id.who.int/icd/entity/1907114935",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1907114935"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Aspirin-induced asthma"
      },
      "foundationReference": "http://id.who.int/icd/entity/1030818265",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1030818265"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Samter syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/330367715",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/330367715"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Photoallergic drug reaction"
      },
      "foundationReference": "http://id.who.int/icd/entity/305500682",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/374142503"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Pseudolymphomatous drug hypersensitivity syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/1697708659",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/923546127/other"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Anaphylaxis due to radiocontrast media"
      },
      "foundationReference": "http://id.who.int/icd/entity/1143499549",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/778830229"
    }
  ],
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/405257730/postcoordinationScale/associatedWith",
      "axisName": "http://id.who.int/icd/schema/associatedWith",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/1583926619",
        "http://id.who.int/icd/release/11/2024-01/mms/1323892810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Drug or pharmacological agents hypersensitivity"
  },
  "definition": {
    "@language": "en",
    "@value": "Drug hypersensitivity reactions are the adverse effects of pharmaceutical formulations (including active drugs and excipients) that clinically resemble allergy. It belongs to type B adverse drug reactions, which are defined by the World Health Organization as the dose-independent, unpredictable, noxious, and unintended response to a drug taken at a dose normally used in humans. It covers many different clinical phenotypes with variable onset and severity."
  }
}